Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Neurology (clinical),Oncology
Reference8 articles.
1. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma;N Engl J Med,2014
2. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial;European Organisation for Research and Treatment of Cancer (EORTC); Canadian Brain Tumor Consortium; CENTRIC study team;Lancet Oncol,2014
3. Response criteria for phase II studies of supratentorial malignant glioma;J Clin Oncol,1990
4. Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology working group;J Clin Oncol,2010
5. Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria;Neuro Oncol,2012
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献